The puzzle of myeloproliferative neoplasms: novel disease-specific mutations and new proposals for diagnostic criteria
- PMID: 25548751
- PMCID: PMC4277999
- DOI: 10.5045/br.2014.49.4.211
The puzzle of myeloproliferative neoplasms: novel disease-specific mutations and new proposals for diagnostic criteria
Conflict of interest statement
No potential conflicts of interest relevant to this article were reported.
References
-
- Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of tumours of haematopoietic and lymphoid tissues. 4th ed. France: IARC Press; 2008.
-
- Tefferi A, Thiele J, Vannucchi AM, Barbui T. An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms. Leukemia. 2014;28:1407–1413. - PubMed
-
- Tefferi A, Lasho TL, Finke C, et al. Type 1 vs type 2 calreticulin mutations in primary myelofibrosis: differences in phenotype and prognostic impact. Leukemia. 2014;28:1568–1570. - PubMed
-
- Barbui T, Thiele J, Carobbio A, et al. Discriminating between essential thrombocythemia and masked polycythemia vera in JAK2 mutated patients. Am J Hematol. 2014;89:588–590. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
